Cargando…
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Research over the last two decades has established ketamine as a safe, effective, fast-acting, and sustained antidepressant that significantly reduces adverse symptoms associated with depression, even in patients who are treatment resistant. Much of this research has evolved within the framework of...
Autores principales: | Muscat, Sherry-Anne, Hartelius, Glenn, Crouch, Courtenay Richards, Morin, Kevin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653702/ https://www.ncbi.nlm.nih.gov/pubmed/34899408 http://dx.doi.org/10.3389/fpsyt.2021.710338 |
Ejemplares similares
-
Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders
por: Hartelius, Glenn, et al.
Publicado: (2023) -
Ketamine-Assisted and Culturally Attuned Trauma Informed Psychotherapy as Adjunct to Traditional Indigenous Healing: Effecting Cultural Collaboration in Canadian Mental Health Care
por: Muscat, Sherry-Anne, et al.
Publicado: (2021) -
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
por: Garel, Nicolas, et al.
Publicado: (2023) -
Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021) -
The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)